These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 22372800)
21. Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Ge ZZ; Chen HM; Gao YJ; Liu WZ; Xu CH; Tan HH; Chen HY; Wei W; Fang JY; Xiao SD Gastroenterology; 2011 Nov; 141(5):1629-37.e1-4. PubMed ID: 21784047 [TBL] [Abstract][Full Text] [Related]
22. Successful Treatment of Recurrent Gastrointestinal Bleeding Due to Small Intestine Angiodysplasia and Multiple Myeloma with Thalidomide: Two Birds with One Stone. Hude I; Batinić J; Kinda SB; Pulanić D Turk J Haematol; 2018 Nov; 35(4):305-306. PubMed ID: 29911985 [No Abstract] [Full Text] [Related]
23. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases. Nardone G; Compare D; Scarpignato C; Rocco A Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688 [TBL] [Abstract][Full Text] [Related]
24. Type IIb von Willebrand disease with angiodysplasias and refractory gastrointestinal bleeding successfully treated with thalidomide. Nomikou E; Tsevrenis V; Gafou A; Bellia M; Theodossiades G Haemophilia; 2009 Nov; 15(6):1340-2. PubMed ID: 19702883 [No Abstract] [Full Text] [Related]
25. [Invalidating and recurrent gastrointestinal bleeding caused by intestinal angiodysplasia: treatment with thalidomide]. Serralta de Colsa D; Arjona Medina I; García Marín A; Sanz Sánchez M; Turégano Fuentes F Rev Esp Enferm Dig; 2008 May; 100(5):306-7. PubMed ID: 18662087 [No Abstract] [Full Text] [Related]
26. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia. Wang XY; Chen Y; Du Q Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1114-6. PubMed ID: 23661527 [TBL] [Abstract][Full Text] [Related]
27. Thalidomide for the treatment of angiodysplasia in a patient with acute upper gastrointestinal haemorrhage. Bond A; Ahmed W BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791122 [TBL] [Abstract][Full Text] [Related]
28. Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy. Jimenez-Saenz M; Romero-Vazquez J; Caunedo-Alvarez A; Maldonado-Perez B; Gutierrez JM Dig Liver Dis; 2010 Mar; 42(3):232-3. PubMed ID: 19574114 [No Abstract] [Full Text] [Related]
29. Thalidomide as treatment for digestive tract angiodysplasias. Heidt J; Langers AM; van der Meer FJ; Brouwer RE Neth J Med; 2006 Dec; 64(11):425-8. PubMed ID: 17179574 [TBL] [Abstract][Full Text] [Related]
30. Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature. Engelen ET; van Galen KP; Schutgens RE Haemophilia; 2015 Jul; 21(4):419-29. PubMed ID: 25929157 [TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of thalidomide in treatment of gastrointestinal bleeding secondary to angioectasias: a systematic review and meta-analysis. Singh S; Mohan BP; Sanaei O; Vinayek R; Dutta S; Dahiya DS; Bhat I; Sharma N; Adler DG Scand J Gastroenterol; 2024 Jul; 59(7):781-787. PubMed ID: 38629130 [TBL] [Abstract][Full Text] [Related]
32. Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia. Chen H; Wu S; Tang M; Zhao R; Zhang Q; Dai Z; Gao Y; Yang S; Li Z; Du Y; Yang A; Zhong L; Lu L; Xu L; Shen X; Liu S; Zhong J; Li X; Lu H; Xiong H; Shen Y; Chen H; Gong S; Xue H; Ge Z N Engl J Med; 2023 Nov; 389(18):1649-1659. PubMed ID: 37913505 [TBL] [Abstract][Full Text] [Related]
33. Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial. Grooteman KV; van Geenen EJ; Drenth JP BMJ Open; 2016 Sep; 6(9):e011442. PubMed ID: 27619827 [TBL] [Abstract][Full Text] [Related]
34. Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia. Bon C; Aparicio T; Vincent M; Mavros M; Bejou B; Raynaud JJ; Zampeli E; Airinei G; Sautereau D; Benamouzig R; Michopoulos S Aliment Pharmacol Ther; 2012 Sep; 36(6):587-93. PubMed ID: 22831465 [TBL] [Abstract][Full Text] [Related]
35. Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review. Almadi M; Ghali PM; Constantin A; Galipeau J; Szilagyi A Can J Gastroenterol; 2009 Sep; 23(9):625-31. PubMed ID: 19816627 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological treatment of gastrointestinal bleeding due to angiodysplasias: A position paper of the Italian Society of Gastroenterology (SIGE). Nardone G; Compare D; Martino A; Rocco A Dig Liver Dis; 2018 Jun; 50(6):542-548. PubMed ID: 29610020 [TBL] [Abstract][Full Text] [Related]
37. Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias? Bowcock SJ; Patrick HE Br J Haematol; 2009 Jul; 146(2):220-2. PubMed ID: 19438503 [No Abstract] [Full Text] [Related]
38. Thalidomide for treatment of severe intestinal bleeding. Bauditz J; Schachschal G; Wedel S; Lochs H Gut; 2004 Apr; 53(4):609-12. PubMed ID: 15016759 [TBL] [Abstract][Full Text] [Related]
39. Von Willebrand's disease and angiodysplasia treated with thalidomide. Hirri HM; Green PJ; Lindsay J Haemophilia; 2006 May; 12(3):285-6. PubMed ID: 16643215 [TBL] [Abstract][Full Text] [Related]
40. Hemorrhagic angiodysplasia of the digestive tract: pathogenesis, diagnosis, and management. Becq A; Rahmi G; Perrod G; Cellier C Gastrointest Endosc; 2017 Nov; 86(5):792-806. PubMed ID: 28554655 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]